Malaysia
Search
Sign In
Change Password
Points
Sign Out
Top Medical News
Dr Poon Shi Hui, a consultant at the Department of Psychiatry at Singapore General Hospital, speaks to Roshini Claire Anthony on the different types of insomnia and the various management strategies deployed for each type.
Cancer patients with more advanced diseases, and those with higher anxiety and depression burdens, suffer from greater pain distress, a recent study has found.
Several pharmacologic interventions, including cannabinoids and selective serotonin reuptake inhibitors (SSRIs), do not appear to be effective in the treatment of cannabis use disorder (CUD), a study has shown.
Physicians and nurses in hospitals equipped with fever clinics or wards for patients with coronavirus disease 2019 (COVID-19) in China report experiencing symptoms of depression, anxiety, insomnia and distress, according to a recent survey.
In the treatment of post-traumatic stress disorder (PTSD), eye movement desensitization and reprocessing (EMDR) and trauma-focused cognitive behavioural therapy (TF-CBT) appear to be most effective at reducing symptoms and increasing remission rates as well as sustaining symptom improvements after therapy has ended, according to the results of a meta-analysis.
Women with successful weight loss can maintain their weight with the help of cognitive behavioural therapy (CBT), with corresponding continuation of reduced energy intake and doing more physical activities which may be beneficial in the long term, a recent study has shown.
Universiti Malaya (UM) recently launched the UM Mental Health Initiative, a platform to push for mental health activities in the university. The initial focus of the initiative will be on students and the university signed a Memorandum of Understanding (MoU) with Johnson & Johnson Sdn Bhd (J&J) on initiatives to innovate teaching and learning in healthcare. Of note is the component on mental health, which is aligned to the MOH’s #Letstalkmindasihat initiative launched in 2019.
Special Reports
Globally, one in four people will be affected by psychiatric or neurological disorders during their lifetime.1 With an estimated affected population of 450 million people, mental disorders are among the leading causes of ill-health and disability worldwide.1 At the recent Lundbeck Neuroscience Symposium held at Hilton Kota Kinabalu from 3–5 November 2017, three renowned key opinion leaders from the field of psychiatry shared their insights into the optimal management of bipolar disorder and schizophrenia.
At a recent Lundbeck Neuroscience Symposium at Hilton Kota Kinabalu, Professor Bernhard Baune discussed important clinical considerations in the management of behavioural and psychological symptoms of dementia (BPSD), focussing on the role of memantine hydrochloride (Ebixa®; Lundbeck).
In this issue of MIMS PsychiatrySupplement, we bring you clinical updates related to managing depression and optimizing functional recovery in patients with depression, as well as a symposium highlight of the Lundbeck Malaysia Neuroscience Symposium.
Conference Reports
Multidomain intervention which includes nutrition, exercise, cognitive training and vascular risk monitoring is effective in preventing dementia, findings from the FINGER study have shown.
_1_2_Square.jpg)
Use of a ginkgo biloba extract on top of standard preventive treatment is shown to improve cognitive function and overall condition after acute ischaemic stroke.
